Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OTC Markets | Financial | Investment Holding Companies | USD 1.50M | -40x | -0.68 | USD 0.00010 | 0% | USD 0.0001 | -25.2% Downside | Overvalued | Good | ||||
NASDAQ | Technology | Software & IT Services | USD 1.37B | -7.4x | -0.25 | USD 4.34 | -0.2% | USD 4.95 | 23.9% Upside | Undervalued | USD 5.50 | 35.1% Upside | Fair | ||
NASDAQ | Technology | Software & IT Services | USD 12.38M | -1.6x | -0.03 | USD 3.82 | -2.3% | USD 5.15 | 12.1% Upside | Fair | USD 13 | 216.3% Upside | Fair | ||
NASDAQ | Healthcare | Healthcare Equipment & Supplies | USD 112.89M | -7.5x | -0.15 | USD 3.26 | -12.6% | USD 1.76 | -57.2% Downside | Expensive | Fair | ||||
NYSE | Consumer Cyclicals | Specialty Retailers | USD 26.11B | 22.6x | 0.2 | USD 127.84 | 0.2% | USD 128.47 | 1.5% Upside | Fair | USD 110 | -7.9% Downside | Good | ||
NASDAQ | Industrials | Professional & Commercial Services | USD 66.42M | -3.5x | -0.08 | USD 2.30 | -32.4% | USD 2.25 | 18.7% Upside | Undervalued | Fair | ||||
NYSE | Technology | Software & IT Services | USD 1.18B | -10.1x | -0.32 | USD 20.51 | 0.1% | USD 24.84 | 14% Upside | Fair | USD 29 | 43.1% Upside | Good | ||
NASDAQ | Healthcare | Biotechnology & Medical Research | USD 2.69B | 61x | 0.52 | USD 18.79 | 2.6% | USD 19.20 | 8.3% Upside | Fair | USD 34.50 | 87.4% Upside | Great | ||
OTC Markets | Consumer Non-Cyclicals | Food & Tobacco | USD 16.36M | -21.4x | -0.49 | USD 0.006 | -7.6% | USD 0.006 | -26.8% Downside | Overvalued | Fair | ||||
OTC Markets | Financial | Investment Holding Companies | USD 7.03M | -21.6x | -0.26 | USD 0.01 | -40% | USD 0.01 | -46% Downside | Overvalued | Great | ||||
NASDAQ | Healthcare | Pharmaceuticals | USD 224.82M | -2x | 0 | USD 3.88 | 0.8% | USD 3.94 | 3.2% Upside | Fair | USD 13 | 218.2% Upside | Fair | ||
NASDAQ | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | USD 2.60B | -13.1x | 2.03 | USD 15.28 | 7.7% | USD 13.30 | -11.5% Downside | Fair | USD 22 | 86.9% Upside | Weak | ||
NASDAQ | Healthcare | Healthcare Equipment & Supplies | USD 307.99M | -5.9x | -0.17 | USD 6.19 | 0.5% | USD 5.67 | -10.2% Downside | Fair | USD 6 | -2.8% Downside | Good | ||
OTC Markets | Industrials | Professional & Commercial Services | USD 10.76M | -4.2x | 0.02 | USD 0.12 | -6.8% | USD 0.08 | -37.1% Downside | Overvalued | Fair | ||||
NASDAQ | Healthcare | Biotechnology & Medical Research | USD 777.13M | -4.5x | 0.03 | USD 14.89 | -0.1% | USD 16.20 | 15.6% Upside | Fair | USD 17.50 | 21.6% Upside | Good | ||
OTC Markets | Energy | Oil & Gas | USD 5.59M | 20x | 0.14 | USD 0.09 | 0% | USD 0.07 | -14.8% Downside | Fair | Good | ||||
OTC Markets | Financial | Investment Banking & Investment Services | USD 9.06M | -7.3x | 0.07 | USD 0.007 | -9.1% | USD 0.002 | -48.7% Downside | Overvalued | Fair | ||||
NASDAQ | Healthcare | Healthcare Equipment & Supplies | USD 922.76M | -15.1x | -0.27 | USD 20.03 | -1% | USD 24.62 | 14.6% Upside | Fair | USD 25 | 16.2% Upside | Good | ||
NASDAQ | Healthcare | Biotechnology & Medical Research | USD 1.80B | -7.2x | -0.63 | USD 20 | -1.5% | USD 21.99 | 12.8% Upside | Fair | USD 36.89 | 85.4% Upside | Fair | ||
OTC Markets | Healthcare | Biotechnology & Medical Research | USD 5.83M | -4.4x | 0.07 | USD 0.04 | 0% | USD 0.02 | -43.6% Downside | Overvalued | Good | ||||
NASDAQ | Consumer Cyclicals | Textiles & Apparel | USD 253.28M | 20x | 5.97 | USD 34.12 | -0.4% | USD 34.73 | -1.3% Downside | Fair | USD 32 | -13.1% Downside | Good | ||
NASDAQ | Healthcare | Biotechnology & Medical Research | USD 1.11B | -3.4x | -0.09 | USD 9.60 | 3.2% | USD 11.12 | 19.8% Upside | Undervalued | USD 18.50 | 108.3% Upside | Fair | ||
NYSE | Healthcare | Pharmaceuticals | USD 395.11M | -0.6x | 0.02 | USD 7.54 | 0.7% | USD 8.79 | 33.9% Upside | Undervalued | USD 8 | 18.2% Upside | Good | ||
NASDAQ | Healthcare | Pharmaceuticals | USD 1.04B | -5.6x | 1.01 | USD 6.69 | 0.2% | USD 5.77 | -12.9% Downside | Fair | USD 14.50 | 122.1% Upside | Good | ||
NASDAQ | Healthcare | Biotechnology & Medical Research | USD 5.57B | -57.7x | -86.24 | USD 50.47 | -2.1% | USD 35.22 | -25.7% Downside | Overvalued | USD 113 | 122.6% Upside | Good | ||
NASDAQ | Consumer Cyclicals | Hotels & Entertainment Services | USD 502.68M | -9.3x | -0.3 | USD 9.39 | -2.1% | USD 7.71 | -14.9% Downside | Fair | USD 12.50 | 54.9% Upside | Good | ||
NASDAQ | Technology | Semiconductors & Semiconductor Equipment | USD 2.94B | -30.1x | 0 | USD 128.43 | 0.2% | USD 112.66 | -7.4% Downside | Fair | USD 140 | 20.9% Upside | Fair | ||
OTC Markets | Technology | Software & IT Services | USD 50.08M | -9.1x | -0.18 | USD 0.00010 | -50% | USD 0.00008 | -22.5% Downside | Overvalued | Weak | ||||
NYSE | Consumer Cyclicals | Hotels & Entertainment Services | USD 10.82B | 261.8x | 3.49 | USD 94.92 | 0.4% | USD 56.19 | -37.6% Downside | Overvalued | USD 90 | -1% Downside | Good | ||
OTC Markets | Industrials | Professional & Commercial Services | USD 948.68K | 1.9x | 0.01 | USD 0.12 | 0% | USD 0.16 | 62% Upside | Bargain | Great |